Simplex Trading
FENC icon

Simplex Trading’s Fennec Pharmaceuticals FENC Stock Holding History

Simplex Trading’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-21,270
Closed -$175K – 8999
2025
Q3 		$199K Sell
21,270
-1,440
-6% -$12.5K ﹤0.01% 4938
2025
Q2 		$188K Buy
22,710
+22,458
+8,912% +$154K ﹤0.01% 4571
2025
Q1 		$1K Buy
+252
New +$1.62K ﹤0.01% 8198
2024
Q4 		– Sell
-21
Closed – – 8840
2024
Q3 		$0 Buy
+21
New +$121 ﹤0.01% 8806
2024
Q1 		– Sell
-12
Closed -$120 – 9143
2023
Q4 		$0 Buy
+12
New +$99 ﹤0.01% 9083
2023
Q1 		– Sell
-2,921
Closed -$27.1K – 9330
2022
Q4 		$28K Buy
+2,921
New +$25.8K ﹤0.01% 6540
2022
Q3 		– Sell
-2,177
Closed -$14.9K – 10188
2022
Q2 		$12K Buy
+2,177
New +$12.6K ﹤0.01% 8117
2022
Q1 		– Sell
-899
Closed -$4.53K – 10683
2021
Q4 		$3K Buy
899
+658
+273% +$4.9K ﹤0.01% 9812
2021
Q3 		$1K Hold
241
– – ﹤0.01% 9633
2021
Q2 		$1K Sell
241
-845
-78% -$5.64K ﹤0.01% 9810
2021
Q1 		$6K Sell
1,086
-874
-45% -$6.58K ﹤0.01% 8145
2020
Q4 		$14K Buy
1,960
+1,853
+1,732% +$14.1K ﹤0.01% 7193
2020
Q3 		$0 Sell
107
-1,253
-92% -$8.83K ﹤0.01% 7990
2020
Q2 		$11K Buy
+1,360
New +$10.1K ﹤0.01% 6590
2019
Q4 		– Sell
-100
Closed – – 7472
2019
Q3 		$0 Buy
+100
New +$441 ﹤0.01% 7422

Other funds holding FENC

RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Potomac Capital Management New York $115M AUM

Simplex Trading's FENC Position: Q4 2025 in Review

Simplex Trading sold out of Fennec Pharmaceuticals (FENC) in Q4 2025, closing a stake of 21,270 shares — an estimated $175K sold.

Simplex Trading first reported a position in FENC in Q3 2019 and held it in 15 quarters. The position peaked at $199K in Q3 2025. 96 funds tracked by Wall St. Rank hold FENC as of Q4 2025.

  • Simplex Trading reported no remaining Fennec Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Simplex Trading sold 21,270 Fennec Pharmaceuticals shares in Q4 2025, an estimated $175K.
  • Simplex Trading first reported a position in Fennec Pharmaceuticals in Q3 2019 and held it in 15 quarters.
  • Simplex Trading's Fennec Pharmaceuticals position peaked at $199K in Q3 2025.
  • 96 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q4 2025.

Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.